View in EDS

Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin-based therapies.

Saved in:
Bibliographic Details
Title: Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin-based therapies.
Authors: Serra I; Department of Physiology and Pharmacology 'V. Erspamer', Sapienza University of Rome, Rome, Italy.; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy., Bisconti E; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy., Vergara D; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy., Giudetti AM; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy., Vari F; Department of Physiology and Pharmacology 'V. Erspamer', Sapienza University of Rome, Rome, Italy.; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.
Source: British journal of pharmacology [Br J Pharmacol] 2026 May 17. Date of Electronic Publication: 2026 May 17.
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5381
DOI:10.1111/bph.70511